Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00465244Phase 3Withdrawn
A Phase 3 trial of levetiracetam in epilepsy, sponsored by Massachusetts General Hospital. Planned start Jan 2008; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00465244.